{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:25:06Z","timestamp":1788456306080,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/cmi.2016.63","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T09:42:22Z","timestamp":1486978942000},"page":"388-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhongming","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runqiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak S","family":"Shoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Maillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Quesniaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beicheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ryffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"62_CR1","doi-asserted-by":"publisher","first-page":"11721","DOI":"10.1074\/jbc.M207728200","volume":"278","author":"C Liu","year":"2003","unstructured":"Liu C, Gaca MD, Swenson ES, Vellucci VF, Reiss M, Wells RG. Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 2003; 278: 11721\u201311728.","journal-title":"J Biol Chem"},{"key":"62_CR2","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis\u2014from bench to bedside. J Hepatol 2003; 38: S38\u2013S53.","journal-title":"J Hepatol"},{"key":"62_CR3","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015; 313: 2263\u20132273.","journal-title":"JAMA"},{"key":"62_CR4","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00204-015-1525-6","volume":"89","author":"RJ Chen","year":"2015","unstructured":"Chen RJ, Wu HH, Wang YJ. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals. Arch Toxicol 2015; 89: 1727\u20131750.","journal-title":"Arch Toxicol"},{"key":"62_CR5","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.clinre.2015.06.015","volume":"39","author":"M Sun","year":"2015","unstructured":"Sun M, Kisseleva T. Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol 2015; 39: S60\u2013S63.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"62_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fmed.2015.00072","volume":"2","author":"F van Dijk","year":"2015","unstructured":"van Dijk F, Olinga P, Poelstra K, Beljaars L. Targeted therapies in liver fibrosis: combining the best parts of platelet-derived growth factor BB and interferon gamma. Front Med 2015; 2: 72.","journal-title":"Front Med"},{"key":"62_CR7","doi-asserted-by":"publisher","first-page":"e0134089","DOI":"10.1371\/journal.pone.0134089","volume":"10","author":"N Jovicic","year":"2015","unstructured":"Jovicic N, Jeftic I, Jovanovic I, Radosavljevic G, Arsenijevic N, Lukic ML et al. Differential Immunometabolic Phenotype in Th1 and Th2 dominant mouse strains in response to high-fat feeding. PLoS One 2015; 10: e0134089.","journal-title":"PLoS One"},{"key":"62_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3109\/14397595.2014.950826","volume":"25","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto M, Shimizu Y, Takahashi H, Yajima H, Yokoyama Y, Ishigami K et al. CCAAT\/enhancer binding protein alpha (C\/EBPalpha)(+) M2 macrophages contribute to fibrosis in IgG4-related disease? Mod Rheumatol 2015; 25: 484\u2013486.","journal-title":"Mod Rheumatol"},{"key":"62_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/intimm\/dxv017","volume":"27","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Huang D, Gao W, Yan J, Zhou W, Hou X et al. Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica. Int Immunol 2015; 27: 317\u2013325.","journal-title":"Int Immunol"},{"key":"62_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.coi.2012.08.009","volume":"24","author":"ST Scanlon","year":"2012","unstructured":"Scanlon ST, McKenzie AN. Type 2 innate lymphoid cells: new players in asthma and allergy. Curr Opin Immunol 2012; 24: 707\u2013712.","journal-title":"Curr Opin Immunol"},{"key":"62_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","volume":"39","author":"T McHedlidze","year":"2013","unstructured":"McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 2013; 39: 357\u2013371.","journal-title":"Immunity"},{"key":"62_CR12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","volume":"162","author":"N Arpaia","year":"2015","unstructured":"Arpaia N, Green JA, Moltedo B, Arvey A, Hemmers S, Yuan S et al. A distinct function of regulatory T cells in tissue protection. Cell 2015; 162: 1078\u20131089.","journal-title":"Cell"},{"key":"62_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.immuni.2015.08.020","volume":"43","author":"CY Chen","year":"2015","unstructured":"Chen CY, Lee JB, Liu B, Ohta S, Wang PY, Kartashov AV et al. Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy. Immunity 2015; 43: 788\u2013802.","journal-title":"Immunity"},{"key":"62_CR14","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.4049\/jimmunol.1400951","volume":"194","author":"B Liu","year":"2015","unstructured":"Liu B, Lee JB, Chen CY, Hershey GK, Wang YH. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol 2015; 194: 3583\u20133593.","journal-title":"J Immunol"},{"key":"62_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.191.6.1069","volume":"191","author":"MJ Townsend","year":"2000","unstructured":"Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN. T1\/ST2-deficient mice demonstrate the importance of T1\/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000; 191: 1069\u20131076.","journal-title":"J Exp Med"},{"key":"62_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/00007890-199306000-00011","volume":"55","author":"S Suzuki","year":"1993","unstructured":"Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265\u20131272.","journal-title":"Transplantation"},{"key":"62_CR17","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","volume":"191","author":"Z Tan","year":"2013","unstructured":"Tan Z, Qian X, Jiang R, Liu Q, Wang Y, Chen C et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 2013; 191: 1835\u20131844.","journal-title":"J Immunol"},{"key":"62_CR18","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1073\/pnas.0812690106","volume":"106","author":"C Cayrol","year":"2009","unstructured":"Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009; 106: 9021\u20139026.","journal-title":"Proc Natl Acad Sci USA"},{"key":"62_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/cmi.2016.5","volume":"13","author":"PA Knolle","year":"2016","unstructured":"Knolle PA, Wohlleber D. Immunological functions of liver sinusoidal endothelial cells. Cell Mol Immunol 2016; 13: 347\u2013353.","journal-title":"Cell Mol Immunol"},{"key":"62_CR20","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1172\/JCI77347","volume":"125","author":"LF Mager","year":"2015","unstructured":"Mager LF, Riether C, Schurch CM, Banz Y, Wasmer MH, Stuber R et al. IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J Clin Invest 2015; 125: 2579\u20132591.","journal-title":"J Clin Invest"},{"key":"62_CR21","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1182\/blood-2014-10-606830","volume":"125","author":"DK Reichenbach","year":"2015","unstructured":"Reichenbach DK, Schwarze V, Matta BM, Tkachev V, Lieberknecht E, Liu Q et al. The IL-33\/ST2 axis augments effector T-cell responses during acute GVHD. Blood 2015; 125: 3183\u20133192.","journal-title":"Blood"},{"key":"62_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson MW, Harmon C, O'Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol 2016; 13: 267\u2013276.","journal-title":"Cell Mol Immunol"},{"key":"62_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nri2692","volume":"10","author":"FY Liew","year":"2010","unstructured":"Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103\u2013110.","journal-title":"Nat Rev Immunol"},{"key":"62_CR24","doi-asserted-by":"crossref","unstructured":"Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016.","DOI":"10.1038\/nri.2016.95"},{"key":"62_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479\u2013490.","journal-title":"Immunity"},{"key":"62_CR26","doi-asserted-by":"publisher","first-page":"10913","DOI":"10.1073\/pnas.0801898105","volume":"105","author":"D Xu","year":"2008","unstructured":"Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008; 105: 10913\u201310918.","journal-title":"Proc Natl Acad Sci USA"},{"key":"62_CR27","doi-asserted-by":"publisher","first-page":"26369","DOI":"10.1074\/jbc.M704916200","volume":"282","author":"H Hayakawa","year":"2007","unstructured":"Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007; 282: 26369\u201326380.","journal-title":"J Biol Chem"},{"key":"62_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","volume":"134","author":"D Li","year":"2014","unstructured":"Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol 2014; 134: 1422\u20131432 e11.","journal-title":"J Allergy Clin Immunol"},{"key":"62_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.intimp.2015.11.015","volume":"30","author":"Q Gao","year":"2016","unstructured":"Gao Q, Li Y, Pan X, Yuan X, Peng X, Li M. Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice. Int Immunopharmacol 2016; 30: 188\u2013193.","journal-title":"Int Immunopharmacol"},{"key":"62_CR30","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","volume":"14","author":"P Marvie","year":"2010","unstructured":"Marvie P, Lisbonne M, L'Helgoualc'h A, Rauch M, Turlin B, Preisser L et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 2010; 14: 1726\u20131739.","journal-title":"J Cell Mol Med"},{"key":"62_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1620\/tjem.234.255","volume":"234","author":"Y Sun","year":"2014","unstructured":"Sun Y, Zhang JY, Lv S, Wang H, Gong M, Du N et al. Interleukin-33 promotes disease progression in patients with primary biliary cirrhosis. Tohoku J Exp Med 2014; 234: 255\u2013261.","journal-title":"Tohoku J Exp Med"},{"key":"62_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.immuni.2009.06.011","volume":"31","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi M, Dixit VM. IL-33 raises alarm. Immunity 2009; 31: 5\u20137.","journal-title":"Immunity"},{"key":"62_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","volume":"43","author":"AB Molofsky","year":"2015","unstructured":"Molofsky AB, Van Gool F, Liang HE, Van Dyken SJ, Nussbaum JC, Lee J et al. Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 2015; 43: 161\u2013174.","journal-title":"Immunity"},{"key":"62_CR34","doi-asserted-by":"publisher","first-page":"G821","DOI":"10.1152\/ajpgi.00178.2010","volume":"299","author":"A Masamune","year":"2010","unstructured":"Masamune A, Watanabe T, Kikuta K, Satoh K, Kanno A, Shimosegawa T. Nuclear expression of interleukin-33 in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2010; 299: G821\u2013G832.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"62_CR35","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1038\/ncomms7970","volume":"6","author":"T Bouchery","year":"2015","unstructured":"Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun 2015; 6: 6970.","journal-title":"Nat Commun"},{"key":"62_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ni.2617","volume":"14","author":"P Licona-Limon","year":"2013","unstructured":"Licona-Limon P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013; 14: 536\u2013542.","journal-title":"Nat Immunol"},{"key":"62_CR37","doi-asserted-by":"publisher","first-page":"18748","DOI":"10.18632\/oncotarget.4349","volume":"6","author":"GY Lui","year":"2015","unstructured":"Lui GY, Kovacevic Z, Richardson V, Merlot AM, Kalinowski DS, Richardson DR. Targeting cancer by binding iron: dissecting cellular signaling pathways. Oncotarget 2015; 6: 18748\u201318779.","journal-title":"Oncotarget"},{"key":"62_CR38","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/labinvest.3700663","volume":"87","author":"M Iikura","year":"2007","unstructured":"Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 2007; 87: 971\u2013978.","journal-title":"Lab Invest"},{"key":"62_CR39","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/hep.25768","volume":"56","author":"N Sakai","year":"2012","unstructured":"Sakai N, Van Sweringen HL, Quillin RC, Schuster R, Blanchard J, Burns JM et al. Interleukin-33 is hepatoprotective during liver ischemia\/reperfusion in mice. Hepatology 2012; 56: 1468\u20131478.","journal-title":"Hepatology"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cmi201663","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cmi201663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cmi201663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:19:03Z","timestamp":1684415943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2016.63","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]},"assertion":[{"value":"18 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}